ArticleFrontiers in medicine2026
Association between dynamic estimated plasma volume trajectories and acute kidney injury after coronary artery bypass grafting.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) is driven partly by venous congestion, yet no single bedside measure fully captures volume status: central venous pressure (CVP) reflects venous pressure, not plasma-volume expansion. Whether dynamic estimated plasma volume status (ePVS), a non-invasive marker derived from routine hemoglobin and hematocrit, conveys AKI-relevant information independent of and complementary to CVP is unknown. Methods: In 4,818 adult patients with coronary artery bypass grafting (CABG) from Medical Information Mart for Intensive Care IV, version 3.0 (MIMIC-IV v3.0), serial ePVS over the first 48 h after admission to the intensive care unit (ICU) was modeled by latent-class linear mixed modeling to identify dynamic phenotypes. The primary outcome was Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury (AKI) stage ≥ 2 within 72 h. Independence from CVP was tested by the ePVS-CVP correlation, progressive adjustment for admission CVP, CVP-stratified analysis with a trajectory by CVP interaction term, and parallel multiple-mediator analysis (24-h ΔHgb, peak CVP, net fluid balance). Forward-time landmark analyses and incremental-value metrics [Δ area under the curve (ΔAUC), net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision-curve analysis] were also performed. Results: Four phenotypes emerged: Low-stable (58.5%), Gradually-increasing (6.9%), Rapid-decline (8.7%), and High-stable (25.9%). Admission ePVS and CVP were essentially uncorrelated (Spearman Conclusion: Four distinct ePVS trajectories within 48 h after CABG carry differential AKI risk. A Gradually-increasing ePVS trajectory after CABG signifies AKI risk that is largely independent of and complementary to CVP, providing a non-invasive volume axis not captured by pressure-based monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.